A large pharmacovigilance analysis of FDA adverse event reports shows no significant lymphoma safety signal with topical calcineurin inhibitors for atopic dermatitis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/topical-calcineurin-inhibitors-show-no-lymphoma-signal-faers-2026a10003af?src=rss
Author :
Publish date : 2026-02-03 03:01:00
Copyright for syndicated content belongs to the linked Source.
